table of content
1 Introduction to Research & Analysis Reports
1.1 AI Drug Development Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global AI Drug Development Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global AI Drug Development Overall Market Size
2.1 Global AI Drug Development Market Size: 2022 VS 2029
2.2 Global AI Drug Development Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top AI Drug Development Players in Global Market
3.2 Top Global AI Drug Development Companies Ranked by Revenue
3.3 Global AI Drug Development Revenue by Companies
3.4 Top 3 and Top 5 AI Drug Development Companies in Global Market, by Revenue in 2022
3.5 Global Companies AI Drug Development Product Type
3.6 Tier 1, Tier 2 and Tier 3 AI Drug Development Players in Global Market
3.6.1 List of Global Tier 1 AI Drug Development Companies
3.6.2 List of Global Tier 2 and Tier 3 AI Drug Development Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global AI Drug Development Market Size Markets, 2022 & 2029
4.1.2 Drug Design
4.1.3 Drug Synthesis
4.1.4 Other
4.2 By Type - Global AI Drug Development Revenue & Forecasts
4.2.1 By Type - Global AI Drug Development Revenue, 2018-2023
4.2.2 By Type - Global AI Drug Development Revenue, 2024-2029
4.2.3 By Type - Global AI Drug Development Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global AI Drug Development Market Size, 2022 & 2029
5.1.2 Tumor
5.1.3 Nervous System
5.1.4 Other
5.2 By Application - Global AI Drug Development Revenue & Forecasts
5.2.1 By Application - Global AI Drug Development Revenue, 2018-2023
5.2.2 By Application - Global AI Drug Development Revenue, 2024-2029
5.2.3 By Application - Global AI Drug Development Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global AI Drug Development Market Size, 2022 & 2029
6.2 By Region - Global AI Drug Development Revenue & Forecasts
6.2.1 By Region - Global AI Drug Development Revenue, 2018-2023
6.2.2 By Region - Global AI Drug Development Revenue, 2024-2029
6.2.3 By Region - Global AI Drug Development Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America AI Drug Development Revenue, 2018-2029
6.3.2 US AI Drug Development Market Size, 2018-2029
6.3.3 Canada AI Drug Development Market Size, 2018-2029
6.3.4 Mexico AI Drug Development Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe AI Drug Development Revenue, 2018-2029
6.4.2 Germany AI Drug Development Market Size, 2018-2029
6.4.3 France AI Drug Development Market Size, 2018-2029
6.4.4 U.K. AI Drug Development Market Size, 2018-2029
6.4.5 Italy AI Drug Development Market Size, 2018-2029
6.4.6 Russia AI Drug Development Market Size, 2018-2029
6.4.7 Nordic Countries AI Drug Development Market Size, 2018-2029
6.4.8 Benelux AI Drug Development Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia AI Drug Development Revenue, 2018-2029
6.5.2 China AI Drug Development Market Size, 2018-2029
6.5.3 Japan AI Drug Development Market Size, 2018-2029
6.5.4 South Korea AI Drug Development Market Size, 2018-2029
6.5.5 Southeast Asia AI Drug Development Market Size, 2018-2029
6.5.6 India AI Drug Development Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America AI Drug Development Revenue, 2018-2029
6.6.2 Brazil AI Drug Development Market Size, 2018-2029
6.6.3 Argentina AI Drug Development Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa AI Drug Development Revenue, 2018-2029
6.7.2 Turkey AI Drug Development Market Size, 2018-2029
6.7.3 Israel AI Drug Development Market Size, 2018-2029
6.7.4 Saudi Arabia AI Drug Development Market Size, 2018-2029
6.7.5 UAE AI Drug Development Market Size, 2018-2029
7 AI Drug Development Companies Profiles
7.1 Insilico Medicine
7.1.1 Insilico Medicine Company Summary
7.1.2 Insilico Medicine Business Overview
7.1.3 Insilico Medicine AI Drug Development Major Product Offerings
7.1.4 Insilico Medicine AI Drug Development Revenue in Global Market (2018-2023)
7.1.5 Insilico Medicine Key News & Latest Developments
7.2 Cyclica
7.2.1 Cyclica Company Summary
7.2.2 Cyclica Business Overview
7.2.3 Cyclica AI Drug Development Major Product Offerings
7.2.4 Cyclica AI Drug Development Revenue in Global Market (2018-2023)
7.2.5 Cyclica Key News & Latest Developments
7.3 XtalPi Inc.
7.3.1 XtalPi Inc. Company Summary
7.3.2 XtalPi Inc. Business Overview
7.3.3 XtalPi Inc. AI Drug Development Major Product Offerings
7.3.4 XtalPi Inc. AI Drug Development Revenue in Global Market (2018-2023)
7.3.5 XtalPi Inc. Key News & Latest Developments
7.4 Exscientia Limited
7.4.1 Exscientia Limited Company Summary
7.4.2 Exscientia Limited Business Overview
7.4.3 Exscientia Limited AI Drug Development Major Product Offerings
7.4.4 Exscientia Limited AI Drug Development Revenue in Global Market (2018-2023)
7.4.5 Exscientia Limited Key News & Latest Developments
7.5 AiCure, LLC
7.5.1 AiCure, LLC Company Summary
7.5.2 AiCure, LLC Business Overview
7.5.3 AiCure, LLC AI Drug Development Major Product Offerings
7.5.4 AiCure, LLC AI Drug Development Revenue in Global Market (2018-2023)
7.5.5 AiCure, LLC Key News & Latest Developments
7.6 Atomwise
7.6.1 Atomwise Company Summary
7.6.2 Atomwise Business Overview
7.6.3 Atomwise AI Drug Development Major Product Offerings
7.6.4 Atomwise AI Drug Development Revenue in Global Market (2018-2023)
7.6.5 Atomwise Key News & Latest Developments
7.7 Biovista Inc.
7.7.1 Biovista Inc. Company Summary
7.7.2 Biovista Inc. Business Overview
7.7.3 Biovista Inc. AI Drug Development Major Product Offerings
7.7.4 Biovista Inc. AI Drug Development Revenue in Global Market (2018-2023)
7.7.5 Biovista Inc. Key News & Latest Developments
7.8 Breg?Inc.
7.8.1 Breg?Inc. Company Summary
7.8.2 Breg?Inc. Business Overview
7.8.3 Breg?Inc. AI Drug Development Major Product Offerings
7.8.4 Breg?Inc. AI Drug Development Revenue in Global Market (2018-2023)
7.8.5 Breg?Inc. Key News & Latest Developments
7.9 Numerate
7.9.1 Numerate Company Summary
7.9.2 Numerate Business Overview
7.9.3 Numerate AI Drug Development Major Product Offerings
7.9.4 Numerate AI Drug Development Revenue in Global Market (2018-2023)
7.9.5 Numerate Key News & Latest Developments
7.10 Cloud Pharmaceuticals
7.10.1 Cloud Pharmaceuticals Company Summary
7.10.2 Cloud Pharmaceuticals Business Overview
7.10.3 Cloud Pharmaceuticals AI Drug Development Major Product Offerings
7.10.4 Cloud Pharmaceuticals AI Drug Development Revenue in Global Market (2018-2023)
7.10.5 Cloud Pharmaceuticals Key News & Latest Developments
7.11 IBM
7.11.1 IBM Company Summary
7.11.2 IBM Business Overview
7.11.3 IBM AI Drug Development Major Product Offerings
7.11.4 IBM AI Drug Development Revenue in Global Market (2018-2023)
7.11.5 IBM Key News & Latest Developments
7.12 NuMedii
7.12.1 NuMedii Company Summary
7.12.2 NuMedii Business Overview
7.12.3 NuMedii AI Drug Development Major Product Offerings
7.12.4 NuMedii AI Drug Development Revenue in Global Market (2018-2023)
7.12.5 NuMedii Key News & Latest Developments
7.13 BenevolentAI
7.13.1 BenevolentAI Company Summary
7.13.2 BenevolentAI Business Overview
7.13.3 BenevolentAI AI Drug Development Major Product Offerings
7.13.4 BenevolentAI AI Drug Development Revenue in Global Market (2018-2023)
7.13.5 BenevolentAI Key News & Latest Developments
7.14 Lam Therapeutics
7.14.1 Lam Therapeutics Company Summary
7.14.2 Lam Therapeutics Business Overview
7.14.3 Lam Therapeutics AI Drug Development Major Product Offerings
7.14.4 Lam Therapeutics AI Drug Development Revenue in Global Market (2018-2023)
7.14.5 Lam Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
